You just read:

Boehringer Ingelheim joins The Leukemia & Lymphoma Society in groundbreaking precision medicine approach to treating acute myeloid leukemia

News provided by

Boehringer Ingelheim Pharmaceuticals

Oct 18, 2016, 12:05 ET